"Medical Oncology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subspecialty of internal medicine concerned with the study of neoplasms.
| Descriptor ID |
D008495
|
| MeSH Number(s) |
H02.403.429.515
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medical Oncology".
Below are MeSH descriptors whose meaning is more specific than "Medical Oncology".
This graph shows the total number of publications written about "Medical Oncology" by people in this website by year, and whether "Medical Oncology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 1 | 2 |
| 2006 | 6 | 1 | 7 |
| 2007 | 8 | 3 | 11 |
| 2008 | 6 | 6 | 12 |
| 2009 | 2 | 9 | 11 |
| 2010 | 6 | 1 | 7 |
| 2011 | 4 | 4 | 8 |
| 2012 | 5 | 3 | 8 |
| 2013 | 7 | 5 | 12 |
| 2014 | 17 | 6 | 23 |
| 2015 | 9 | 2 | 11 |
| 2016 | 12 | 6 | 18 |
| 2017 | 12 | 5 | 17 |
| 2018 | 9 | 5 | 14 |
| 2019 | 18 | 2 | 20 |
| 2020 | 12 | 9 | 21 |
| 2021 | 13 | 15 | 28 |
| 2022 | 5 | 10 | 15 |
| 2023 | 3 | 12 | 15 |
| 2024 | 8 | 16 | 24 |
| 2025 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medical Oncology" by people in Profiles.
-
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025. J Natl Compr Canc Netw. 2025 05; 23(5):132-140.
-
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 05; 23(5):169-191.
-
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025. J Natl Compr Canc Netw. 2025 04; 23(4).
-
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients. Oncotarget. 2025 Mar 12; 16:140-162.
-
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025. J Natl Compr Canc Netw. 2025 Mar; 23(3):66-75.
-
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 02; 23(2):41-62.
-
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 01; 23(1).
-
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2024 12; 22(10):695-711.
-
Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Nov; 22(9):617-644.
-
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024. J Natl Compr Canc Netw. 2024 Nov; 22(9):582-592.